SEVOFLURANE Inhalation Vapour, liquid Ref.[9254] Active ingredients: Sevoflurane

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2020  Publisher: AbbVie Ltd., Maidenhead, SL6 4UB, United Kingdom

Product name and form

Sevoflurane.

Pharmaceutical Form

Sevoflurane is a nonflammable volatile liquid. Sevoflurane is administered via inhalation of the vaporised liquid.

Qualitative and quantitative composition

The finished product is comprised only of the active ingredient (sevoflurane).

Active Ingredient Description
Sevoflurane

Sevoflurane is used as an inhalational anaesthetic for induction and maintenance of general anesthesia. As with all other inhalation agents sevoflurane depresses cardiovascular function in a dose related fashion. In patients with normal intracranial pressure (ICP), sevoflurane had minimal effect on ICP and preserved CO2 responsiveness.

List of Excipients

Water (as a Lewis Acid Inhibitor).

Pack sizes and marketing

100ml and 250ml amber polyethylene napthalate (PEN) bottles.

Not all pack sizes may be marketed.

Marketing authorization holder

AbbVie Ltd., Maidenhead, SL6 4UB, United Kingdom

Marketing authorization dates and numbers

PL 41042/0004

1 September 1995

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.